The increase in geriatric patients remains a primary catalyst for market growth. As chronic kidney disease becomes more prevalent among the elderly—often complicated by diabetes and hypertension—peritoneal dialysis offers a critical advantage. Unlike hemodialysis, which typically requires frequent hospital visits, this method allows patients to maintain independence at home. Clinical evidence suggests that the approach preserves residual kidney function more effectively and reduces the overall risk of infection associated with clinical-level procedures.

Product demand is currently anchored by peritoneal solution bags, which command the largest market share due to their nature as single-use, high-frequency consumables. While dialysis machines represent a one-time capital investment, the constant requirement for these bags ensures a steady revenue stream for manufacturers. Continuous Ambulatory Peritoneal Dialysis remains the dominant treatment modality, favored for its gentle impact on renal health and reduced hospitalization rates. Regionally, the Asia Pacific market is expected to outpace others, with a projected growth rate of 7.6%, spurred by government healthcare reforms aimed at expanding dialysis access to underserved and low-income populations.